Search research articles
Contact Us
Filters
Showing results (281-290 of 361) with videos related to
Page
of 37
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
April 1, 1997
Determination of production of nitric oxide by lower airways of humans--theory
R W Hyde, E J Geigel, A J Olszowka, et al.
Regulatory Peptides
|
August 27, 1996
Characterization of novel peptoid agonists for the CCK-A receptor
J Hughes, G J Dockray, D Hill, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
January 8, 2025
Multicomponent telerehabilitation program for veterans with multimorbidity: A randomized controlled feasibility study
Michelle R Rauzi, Lauren M Abbate, Laura Churchill, et al.
Biochimica Et Biophysica Acta
|
June 2, 2009
Gene expression of synaptosomal-associated protein 25 (SNAP-25) in the prefrontal cortex of the spontaneously hypertensive rat (SHR)
Qi Li, Jack H Wong, Gang Lu, et al.
Schweizer Archiv Fur Tierheilkunde
|
June 5, 2009
Sonographic findings in an alpaca with Mycobacterium kansasii infection
U Braun, M Previtali, A Gautschi, et al.
Psychological Services
|
June 16, 2025
Facilitating assessment of symptoms and behaviors using a smartphone application to identify at-risk sailors
Lisa A Brenner, Jeri E Forster, Kelly A Stearns-Yoder, et al.
Muscle & Nerve
|
January 20, 2021
Suicide among veterans with amyotrophic lateral sclerosis
Emily M Lund, Trisha A Hostetter, Jeri E Forster, et al.
Physical Therapy
|
December 16, 2023
Incorporating Functional Strength Integration Techniques During Total Hip Arthroplasty Rehabilitation: A Randomized Controlled Trial
Dana L Judd, Victor Cheuy, Amy Peters, et al.
Statistical Methods in Medical Research
|
June 17, 2015
Accounting for dropout reason in longitudinal studies with nonignorable dropout
Camille M Moore, Samantha MaWhinney, Jeri E Forster, et al.
Clinical and Vaccine Immunology : CVI
|
April 11, 2008
Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy
Cara C Wilson, Mark J Newman, Brian D Livingston, et al.
Page
of 37
Search research articles
Search
Showing results (281-290 of 361) with videos related to
Sort By:
Page
of 37
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
April 1, 1997
Determination of production of nitric oxide by lower airways of humans--theory
R W Hyde, E J Geigel, A J Olszowka, et al.
Regulatory Peptides
|
August 27, 1996
Characterization of novel peptoid agonists for the CCK-A receptor
J Hughes, G J Dockray, D Hill, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
January 8, 2025
Multicomponent telerehabilitation program for veterans with multimorbidity: A randomized controlled feasibility study
Michelle R Rauzi, Lauren M Abbate, Laura Churchill, et al.
Biochimica Et Biophysica Acta
|
June 2, 2009
Gene expression of synaptosomal-associated protein 25 (SNAP-25) in the prefrontal cortex of the spontaneously hypertensive rat (SHR)
Qi Li, Jack H Wong, Gang Lu, et al.
Schweizer Archiv Fur Tierheilkunde
|
June 5, 2009
Sonographic findings in an alpaca with Mycobacterium kansasii infection
U Braun, M Previtali, A Gautschi, et al.
Psychological Services
|
June 16, 2025
Facilitating assessment of symptoms and behaviors using a smartphone application to identify at-risk sailors
Lisa A Brenner, Jeri E Forster, Kelly A Stearns-Yoder, et al.
Muscle & Nerve
|
January 20, 2021
Suicide among veterans with amyotrophic lateral sclerosis
Emily M Lund, Trisha A Hostetter, Jeri E Forster, et al.
Physical Therapy
|
December 16, 2023
Incorporating Functional Strength Integration Techniques During Total Hip Arthroplasty Rehabilitation: A Randomized Controlled Trial
Dana L Judd, Victor Cheuy, Amy Peters, et al.
Statistical Methods in Medical Research
|
June 17, 2015
Accounting for dropout reason in longitudinal studies with nonignorable dropout
Camille M Moore, Samantha MaWhinney, Jeri E Forster, et al.
Clinical and Vaccine Immunology : CVI
|
April 11, 2008
Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy
Cara C Wilson, Mark J Newman, Brian D Livingston, et al.
Page
of 37